Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             73 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Boxed Warning for Montelukast: The FDA Perspective Clarridge, Katherine

9 7 p. 2638-2641
artikel
2 A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies Shaker, Marcus

9 7 p. 2658-2668.e3
artikel
3 African American Children Are More Likely to Be Allergic to Shellfish and Finfish: Findings from FORWARD, a Multisite Cohort Study Mahdavinia, Mahboobeh

9 7 p. 2867-2873.e1
artikel
4 Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines Hourihane, Jonathan O’B.

9 7 p. 2562-2566
artikel
5 A Special Thank-You to Our Fellow-in-Training and Faculty Reviewers
9 7 p. 2555
artikel
6 Aspergillus-related diseases in a cohort of patients with severe asthma: A SANI single-center report Solidoro, Paolo

9 7 p. 2920-2922.e2
artikel
7 Association Between Statin Medication and Asthma/Asthma Exacerbation in a National Health Screening Cohort Kim, Joo-Hee

9 7 p. 2783-2791
artikel
8 Asthma and COVID-19 Singh, Pramil N.

9 7 p. 2939
artikel
9 Asthma Patients Who Stop Asthma Biologics Have a Similar Risk of Asthma Exacerbations as Those Who Continue Asthma Biologics Jeffery, Molly M.

9 7 p. 2742-2750.e1
artikel
10 Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases Guan, Wei-jie

9 7 p. 2645-2655.e14
artikel
11 Chronic Rhinosinusitis of Odontogenic Origin Clark, James H.

9 7 p. 2894-2895
artikel
12 Clinical disparity of primary antibody deficiency patients at a safety net hospital Wallace, Luke J.

9 7 p. 2923-2925.e1
artikel
13 Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity Milito, Cinzia

9 7 p. 2904-2906.e2
artikel
14 Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry Denton, Eve

9 7 p. 2680-2688.e7
artikel
15 CME Exam: Management Strategies to Reduce Exacerbations in non-T2 Asthma
9 7 p. 2598
artikel
16 CME Exam: Prevention and Outpatient Treatment of Asthma Exacerbations in Children
9 7 p. 2577
artikel
17 CME Exam: Prevention and Treatment of Asthma Exacerbations in Adults
9 7 p. 2587
artikel
18 Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma Eger, Katrien

9 7 p. 2913-2915
artikel
19 Concerns about the approach of measuring allergens in early introduction foods for prevention of food allergy Weihe, Olivia

9 7 p. 2944-2945
artikel
20 Continuing Medical Education Calendar
9 7 p. A35-A36
artikel
21 Cover 1
9 7 p. OFC
artikel
22 COVID-19 in a series of patients with aspirin-exacerbated respiratory disease White, Andrew A.

9 7 p. 2900-2903
artikel
23 COVID-19 “infodemics” and asthmatic children: The return to school challenge Boechat, José Laerte

9 7 p. 2940
artikel
24 Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score Pérez de Llano, Luis

9 7 p. 2725-2731
artikel
25 Editorial Board
9 7 p. A31
artikel
26 Effect of COVID-19 on asthma exacerbation Salciccioli, Justin D.

9 7 p. 2896-2899.e1
artikel
27 Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting Bavaro, Nicole

9 7 p. 2910-2912.e1
artikel
28 Exacerbation-Prone Asthma: A Biological Phenotype or a Social Construct Federico, Monica J.

9 7 p. 2627-2634
artikel
29 Factors Associated with Frequent Exacerbations in the UK Severe Asthma Registry Yang, Freda

9 7 p. 2691-2701.e1
artikel
30 Fruit-Induced Anaphylaxis: Clinical Presentation and Management Gabrielli, Sofianne

9 7 p. 2825-2830.e2
artikel
31 Hormone Replacement Therapy and Risk of Severe Asthma Exacerbation in Perimenopausal and Postmenopausal Women: 17-Year National Cohort Study Nwaru, Bright I.

9 7 p. 2751-2760.e1
artikel
32 Immune Dysregulation in Human ITCH Deficiency Successfully Treated with Hematopoietic Cell Transplantation Patel, Trusha

9 7 p. 2885-2893.e3
artikel
33 Impact of Rapid Transition to Telemedicine-Based Delivery on Allergy/Immunology Care During COVID-19 Tsao, Lulu R.

9 7 p. 2672-2679.e2
artikel
34 Inflammatory T2 Biomarkers in Severe Asthma Patients: The First Step to Precision Medicine Bossios, Apostolos

9 7 p. 2689-2690
artikel
35 Information for Readers
9 7 p. A32
artikel
36 International multicenter experience of transjugular intrahepatic portosystemic shunt implantation in patients with common variable immunodeficiency Globig, Anna-Maria

9 7 p. 2931-2935.e1
artikel
37 Management of Asthma Exacerbations in the Emergency Department Hasegawa, Kohei

9 7 p. 2599-2610
artikel
38 Management Strategies to Reduce Exacerbations in non-T2 Asthma Murphy, Ryan C.

9 7 p. 2588-2597
artikel
39 Mechanics and Economics of a Negative Pressure Pulmonary Function Lab in the COVID-19 Era Olsen, Timothy C.

9 7 p. 2936-2938
artikel
40 Mechanisms and Treatment of the Diverse Presentations of Acute Wheezing and Asthma Gern, James E.

9 7 p. 2635-2637
artikel
41 Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry Thomas, Dennis

9 7 p. 2715-2724.e5
artikel
42 Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose? Akdime, Florie

9 7 p. 2942-2943
artikel
43 Mepolizumab-responsive Kimura disease Kinoshita, Manao

9 7 p. 2928-2930
artikel
44 More Data on Risks and Outcomes of COVID-19 in Asthma, COPD, and Bronchiectasis Chung, Kian Fan

9 7 p. 2656-2657
artikel
45 Moving FORWARD Toward Racial Equity in Food Allergy Davis, Carla M.

9 7 p. 2874-2875
artikel
46 Novel Treatment-Refractory Preschool Wheeze Phenotypes Identified by Cluster Analysis of Lung Lavage Constituents Teague, W. Gerald

9 7 p. 2792-2801.e4
artikel
47 Original Article Highlights From This Issue
9 7 p. A21-A27
artikel
48 Patient-Selected Treatment Goals in Severe Asthma Mulvey, Christopher

9 7 p. 2732-2741.e1
artikel
49 Performance of Eosinophil Cationic Protein as a Biomarker in Asthmatic Children Shah, Sheel N.

9 7 p. 2761-2769.e2
artikel
50 Practice Notes from the AAAI
9 7 p. A33-A34
artikel
51 Predicting Severe Asthma Exacerbations in Children: Blueprint for Today and Tomorrow Navanandan, Nidhya

9 7 p. 2619-2626
artikel
52 Predictors of Asthma Control and Exacerbations: A Real-World Study Racine, Geneviève

9 7 p. 2802-2811.e2
artikel
53 Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016 Silverberg, Jonathan I.

9 7 p. 2853-2866.e14
artikel
54 Prevention and Outpatient Treatment of Asthma Exacerbations in Children Murray, Clare S.

9 7 p. 2567-2576
artikel
55 Prevention and Treatment of Asthma Exacerbations in Adults Menzies-Gow, Andrew

9 7 p. 2578-2586
artikel
56 Racial, Ethnic, and Socioeconomic Disparities in the Diagnosis and Management of Primary Immunodeficiencies Breidenbaugh, Marc

9 7 p. 2926-2927
artikel
57 Real-life small airway outcomes in severe asthma patients receiving biologic therapies Chan, Rory

9 7 p. 2907-2909
artikel
58 Real-World Effectiveness of Omalizumab in Severe Allergic Asthma: A Meta-Analysis of Observational Studies Bousquet, Jean

9 7 p. 2702-2714
artikel
59 Reply to “Concerns about the approach of measuring allergens in early introduction foods for prevention of food allergy” Filep, Stephanie

9 7 p. 2945-2946
artikel
60 Reply to “Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?” Caminati, Marco

9 7 p. 2943-2944
artikel
61 Table of Contents
9 7 p. A6, A8, A10, A12, A14, A16-A20
artikel
62 The association of plasma IL-6 with measures of asthma morbidity in a moderate-severe pediatric cohort aged 6-18 years Permaul, Perdita

9 7 p. 2916-2919.e2
artikel
63 The Cost-Effectiveness of Preschool Peanut Oral Immunotherapy in the Real-World Setting Shaker, Marcus

9 7 p. 2876-2884.e4
artikel
64 The hidden allergen: Triton X-100, a derivative of polyethylene glycol Herman, Sari M.

9 7 p. 2941
artikel
65 The impact of inhaled corticosteroid on SARS-CoV2 infection Lai, Chih-Cheng

9 7 p. 2939-2940
artikel
66 The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis Shaker, Marcus

9 7 p. 2556-2561
artikel
67 The Importance of Binomial Nomenclature for the Identification of Pollen Aeroallergens Ramon, German Dario

9 7 p. 2642-2644
artikel
68 Total IgE Variability Is Associated with Future Asthma Exacerbations: A 1-Year Prospective Cohort Study Yuan, Yu Lai

9 7 p. 2812-2824
artikel
69 Treatable Traits in Elderly Asthmatics from the Australasian Severe Asthma Network: A Prospective Cohort Study Wu, Wen Wen

9 7 p. 2770-2782
artikel
70 Trends in Emergency Department Visits and Hospitalizations for Acute Allergic Reactions and Anaphylaxis Among US Older Adults: 2006-2014 Arroyo, Anna Chen

9 7 p. 2831-2843.e8
artikel
71 What a Dime Can Buy You Lang, David M.

9 7 p. 2669-2671
artikel
72 Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food Kraft, Magdalena

9 7 p. 2844-2852.e5
artikel
73 Which Wheezing Preschoolers Should be Treated for Asthma? Bacharier, Leonard B.

9 7 p. 2611-2618
artikel
                             73 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland